| 
						U.S. stock futures rise 
						after Clinton seen winner of debate 
		 Send a link to a friend 
		
		 [October 10, 2016] 
		By Yashaswini Swamynathan 
 (Reuters) -
		 
		U.S. 
		stock index futures rose on Monday after Democrat Hillary Clinton was 
		widely seen as the winner of the second presidential debate.
 
 * A Clinton presidency would be more positive for the markets because 
		her positions are more well known than those of her Republican rival 
		Donald Trump, according to a Reuters poll.
 
 * A CNN/ORC snap poll of debate watchers found that 57 percent thought 
		Clinton won the encounter, versus 34 percent for Trump.
 
 * Investors are also bracing for the third-quarter earnings season, 
		which unofficially kicks off on Tuesday when aluminum producer Alcoa <AA.N> 
		reports. Earnings of S&P 500 companies are expected to drop 0.7 percent, 
		according to Thomson Reuters data.
 
 * Wall Street slipped on Friday as the pound dropped and a 
		weaker-than-expected U.S. payrolls number did little to dampen hopes of 
		an interest rate hike by the end of this year.
 
		
		 
		* The dollar, which has been swinging between gains and losses for the 
		past five days, was up 0.11 percent against a basket of major 
		currencies. The pound <GBP=> fell again on Monday.
 * The U.S. bond market was closed for the Columbus Day holiday.
 
 * Shares of Mylan soared 12 percent in heavy premarket trading. The 
		drugmaker on Friday said it would pay $465 million to settle questions 
		over whether it underpaid U.S. government healthcare programs by 
		misclassifying its EpiPen emergency allergy treatment.
 
		
		* Electric carmaker Tesla was up 2.85 percent at $202.21 after CEO Elon 
		Musk said the company would not need to raise equity or corporate debt 
		in the fourth quarter for its planned acquisition of SolarCity Corp, 
		whose shares also rose. 
			
            [to top of second column] | 
            
			 
            
			Traders work on the floor of the New York Stock Exchange (NYSE) as 
			the market closes in New York, U.S., October 3, 2016. REUTERS/Lucas 
			Jackson 
            
			
 
* 
Merck rose 3.1 percent after clinical data showed its Keytruda immunotherapy 
offered big benefits in previously untreated lung cancer patients, either when 
given on its own or with chemotherapy. 
* 
Twitter dropped 6.7 percent and was the top mover premarket after a Bloomberg 
report on Saturday that potential bidders, including Salesforce.com, were said 
to have backed off.
 Futures snapshot at 6:59 a.m. ET:
 
 * Dow e-minis  were up 51 points, or 0.28 percent, with 17,155 contracts 
changing hands.
 
 * S&P 500 e-minis  were up 7.5 points, or 0.35 percent, with 115,986 
contracts traded.
 
 * Nasdaq 100 e-minis were up 15.5 points, or 0.32 percent, on volume of 14,050 
contracts.
 
 (Reporting by Yashaswini Swamynathan in Bengaluru; Editing by Anil D'Silva)
 
				 
			[© 2016 Thomson Reuters. All rights 
				reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			
			 |